Saturday, December 23, 2006

Eli Lilly Responses to NYT Articles on Zyprexa Misconduct

Point of Law notes that Eli Lilly has responded to the New York Times articles discussing Zyprexa misconduct.  Here are links to Eli Lilly's response to the 12/17 NYT article, Eli Lilly's response to the 12/18 NYT article, and Eli Lilly's response to the 12/21 NYT article.

BGS

http://lawprofessors.typepad.com/mass_tort_litigation/2006/12/eli_lilly_respo.html

Zyprexa | Permalink

TrackBack URL for this entry:

http://www.typepad.com/services/trackback/6a00d8341bfae553ef00d8350892fc69e2

Listed below are links to weblogs that reference Eli Lilly Responses to NYT Articles on Zyprexa Misconduct:

Comments


Eli Lilly makes billions on diabetes treatment and also gets $4.2 billion a year in sales of their biggest cash cow Zyprexa which has been scandalized as *causing* diabetes as a major side effect.
Not fair~Daniel Haszard

Posted by: Daniel Haszard | Jan 1, 2007 1:19:32 PM

Post a comment